Clarus Corp Debt Disclosure
NOTE 8. LONG-TERM DEBT, NET
As of December 31, 2025, the Company maintained no long-term debt. Long-term debt as of December 31, 2024, was as follows:
December 31, 2024 | ||
Other debt (a) | $ | 1,888 |
1,888 | ||
Less current portion | (1,888) | |
$ | - | |
| (a) | On December 5, 2024, pursuant to the RockyMounts Purchase Agreement, Clarus and its wholly-owned subsidiary, Rhino-Rack USA LLC, issued a promissory note in favor of RockyMounts, Inc. in the principal amount of $2,000, which was fully paid on December 5, 2025. Imputed interest was included within the principal amount and the fair value of the note was $1,878 on the date of issuance. There were no remaining amounts outstanding as of December 31, 2025. As of December 31, 2024, the borrowing rate was 6.5%. |
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 5, 2026 | Showing above |
| 2023 | Mar 7, 2024 | |
| 2022 | Feb 27, 2023 | |
| 2021 | Mar 7, 2022 | |
| 2020 | Mar 8, 2021 | |
| 2019 | Mar 9, 2020 | |
| 2018 | Mar 4, 2019 | |
| 2017 | Mar 12, 2018 | |
| 2016 | Mar 6, 2017 | |
| 2015 | Mar 15, 2016 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.